From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma
about
Proteomics and peptidomics: moving toward precision medicine in urological malignanciesPrecision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality?Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesRenal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrumWeb-based tools for microRNAs involved in human cancer.Informatics for practicing anatomical pathologists: marking a new era in pathology practice.MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer.Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell CarcinomaLIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma.RCDB: Renal Cancer Gene Database.MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.miR-31 is a broad regulator of β1-integrin expression and function in cancer cells.miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215Glucose restriction induces cell death in parental but not in homeodomain-interacting protein kinase 2-depleted RKO colon cancer cells: molecular mechanisms and implications for tumor therapyLow level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinomaGenetic profiles in renal tumors.Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis.Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.What can molecular pathology contribute to the management of renal cell carcinoma?Molecular aspects of renal cell carcinoma: a review.Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.Molecular profiling of small renal masses: Current status and future directions.Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study.Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.Synchronous pulmonary metastases from renal cell carcinoma--a whole nation study on prevalence and potential resectability.Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization.Key elements involved in Epstein-Barr virus-associated gastric cancer and their network regulation
P2860
Q26749401-73A13D3B-5B1E-416D-A303-901829A0E7FCQ26764984-360B99C0-4BA5-45CA-9808-CA73A02884ACQ27007065-85A84AE5-2E21-4C7B-9AB3-39FED15D8DFDQ28298351-5A96891D-CDCB-48ED-8E2E-65015139B381Q30489440-F0FB2DD3-ADD4-48BA-BE51-E7780F89CE7CQ33524782-C00268C9-9ECE-4D97-A661-1D51DC589603Q33724744-047F5D3B-E447-4594-BC3D-5624AF5CC9CDQ33947929-7D6C7200-5D87-48DA-A15D-B21792B3E2B1Q34153409-DCBF8DB6-29D5-4F78-947E-5F86F73A6C01Q34274878-915BD347-FF70-4BB3-B74C-CE3F911D8B83Q34685896-332AF86A-B80E-40B5-8B62-5FA85CFCEE58Q35032590-0EFB076F-46CB-4127-9A29-57F3B02AFA63Q35560738-BA96A65D-A4CE-496A-A91A-1BDD50BFA38FQ35623283-714B48AD-8531-4335-9642-21D2A0C6D40DQ36907145-C1B1CB06-DD9A-41CA-B372-80844663C8C3Q37584289-83D00723-41E4-41E2-AD36-4B20BDAC3924Q37615533-C72D0D46-4176-4B8B-9218-258C448C15ABQ37632111-E748E8F4-1D15-4F1F-AB6C-98CE1F9EB0D1Q37660323-F6D79560-C3DB-4A46-A75D-759E5FABA30FQ37864528-FF1C4144-5E64-472B-B9F3-13970384E8CEQ37942072-E116D795-8A8B-4035-870F-94D2A73899BCQ38484441-C77EE2E6-8380-4CF9-A214-E1BF0CBEF642Q39923478-1553B9A6-75C5-4405-943E-6E2F0DA00475Q40005099-F845089A-C727-4A90-8DB6-26A63BD58144Q42109826-4795C075-FED3-4CCC-BEF0-0B9BF99B9ADAQ42471722-A05E7DC5-5C6F-4542-A934-ABD28D0659DFQ44046746-048C920B-A0E1-4E4C-BEDE-AEC776E8658AQ44508865-451A94AC-C742-4689-85E3-A7A6034B2BD4Q49425132-60EBBDB6-B9E9-4005-8717-B135DD697BB0Q58706780-137FD622-C9D7-4FDE-98AE-964C0BE5E744
P2860
From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
From bench to bedside: current ...... filing in renal cell carcinoma
@en
From bench to bedside: current ...... iling in renal cell carcinoma.
@nl
type
label
From bench to bedside: current ...... filing in renal cell carcinoma
@en
From bench to bedside: current ...... iling in renal cell carcinoma.
@nl
prefLabel
From bench to bedside: current ...... filing in renal cell carcinoma
@en
From bench to bedside: current ...... iling in renal cell carcinoma.
@nl
P2093
P2860
P921
P356
P1433
P1476
From bench to bedside: current ...... filing in renal cell carcinoma
@en
P2093
Androu Arsanious
Georg A Bjarnason
George M Yousef
P2860
P2888
P356
10.1186/1476-4598-8-20
P5008
P577
2009-03-17T00:00:00Z
P5875
P6179
1017842227